Entera Bio
Develops oral peptide therapies through its N-Tab delivery platform.
$3.03
After-hours close−0.01 (−0.33%)
At close$3.04(−1.30%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 15.97%7.87M sharesInsiders 4.47%2.20M sharesOther 79.56%39.21M shares
Shares outstanding 49.29M · Float 40.37M · 81.9% free float
Institutions13F, as of Mar 31, 2026
26 holders · 7.87M shares · 8 new positions · 13 increased · 7 reduced · 4 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Knoll Capital Management, LLC | 5.88M | 11.93% | 0 | May 15, 2026 |
| Renaissance Technologies LLC | 473.4K | 0.96% | +365.4K | May 14, 2026 |
| Parkman Healthcare Partners LLC | 288.7K | 0.59% | +13.6K | May 15, 2026 |
| Citadel Advisors LLC | 245.6K | 0.50% | +205.3K | May 15, 2026 |
| Seven Fleet Capital Management LP | 205.5K | 0.42% | +70.2K | Jun 4, 2026 |
| Marshall Wace, LLP | 195.8K | 0.40% | −431.6K | May 15, 2026 |
| Northern Trust Corp | 146.9K | 0.30% | −1.8K | May 14, 2026 |
| XTX Topco Ltd | 131.6K | 0.27% | +131.6K | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Opko Health, Inc. | 8.10% | 3.69M | 13G | Apr 2, 2025 ↗ |
| TCG Crossover GP III, LLC | 7.10% | 12.25M | 13G | Aug 4, 2026 ↗ |
| Biotechnology Value Fund L P | 5.30% | 9.17M | 13D | Aug 4, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Miranda Jayne Toledano | director, officer: Chief Executive Officer | 774.1K | 1.57% | Jul 16, 2026 |
| Gerald M. Lieberman | director | 338.5K | 0.69% | Jan 2, 2026 |
| Sean Ellis | director | 208.1K | 0.42% | Aug 7, 2026 |
| Gregory Burshtein | officer: Chief of R&D | 189.0K | 0.38% | May 8, 2026 |
| Dana Yaacov-Garbeli | officer: Chief Financial Officer | 171.4K | 0.35% | May 8, 2026 |
| Hillel Galitzer | officer: Chief Operating Officer | 163.6K | 0.33% | May 8, 2026 |
| Haya Taitel | director | 119.3K | 0.24% | Aug 7, 2026 |
| Yonatan Malca | director | 100.2K | 0.20% | Aug 7, 2026 |
| Gerald M. Ostrov | director | 75.7K | 0.15% | Jan 2, 2026 |
| Geno J. Germano | director | 65.0K | 0.13% | Aug 7, 2026 |
1 ten-percent owner holds 5.53M shares by Form 4, outside the officers-and-directors figure above · 5 people have not refiled in the last 18 months (639.4K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Mar 9, 2026 | Geno J. Germanodirector | Purchase | 20,000 | $1.30 | 40,000 |
| Mar 5, 2026 | Sean Ellisdirector | Purchase | 10,000 | $1.23 | 188,098 |
| Feb 9, 2026 | Sean Ellisdirector | Purchase | 18,000 | $1.24 | 178,098 |
| Feb 10, 2026 | Geno J. Germanodirector | Purchase | 20,000 | $1.49 | 0 |
| Feb 10, 2026 | Haya Taiteldirector | Purchase | 7,500 | $1.48 | 0 |
| Dec 29, 2025 | Miranda Jayne Toledanodirector, officer: Chief Executive Officer | Purchase | 11,000 | $1.81 | 426,575 |
CongressHouse and Senate disclosures
Not reported.